# Effect of Simvastatin on CF Airway Inflammation

> **NCT00255242** · PHASE1 · COMPLETED · sponsor: **Akron Children's Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Simvastatin treatment for 28 days

## Key facts

- **NCT ID:** NCT00255242
- **Lead sponsor:** Akron Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2008-03
- **Final completion:** 2009-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2009-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255242, "Effect of Simvastatin on CF Airway Inflammation". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00255242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*